This invention concerns a method of synthesizing Azelaic Acid. Particular reference is made to providing a new synthetic process for preparing azelaic acid in large scale with high purity (e.g., >99.7% with any individual impurity not more than 0.1%), which can be used as an active pharmaceutical ingredient.

This invention concerns a method of synthesizing Azelaic Acid. Particular reference is made to providing a new synthetic process for preparing azelaic acid in large scale with high purity (e.g., >99.7% with any individual impurity not more than 0.1%), which can be used as an active pharmaceutical ingredient.

A method is provided for producing polyimides by polycondensation of previously produced stoichiometric salts from polycarboxylic acids or their polyanhydrides and polyamines by heating the salts for dehydration. In the method, a) an aqueous solution of a water-soluble stoichiometric salt is produced from polycarboxylic acid and polyamine; b) the aqueous solution undergoes a processing step; and c) the salt contained in the solution is simultaneously or subsequently polycondensed, by heating to form a polyimide.

A method is provided for producing polyimides by polycondensation of previously produced stoichiometric salts from polycarboxylic acids or their polyanhydrides and polyamines by heating the salts for dehydration. In the method, a) an aqueous solution of a water-soluble stoichiometric salt is produced from polycarboxylic acid and polyamine; b) the aqueous solution undergoes a processing step; and c) the salt contained in the solution is simultaneously or subsequently polycondensed, by heating to form a polyimide.

Disclosed are compositions and methods for inactivating one or more enzymes in a biological sample.

Disclosed are compositions and methods for inactivating one or more enzymes in a biological sample.

The present disclosure provides a pressure-reducing and injection-enhancing anti-scaling agent for low-permeability water-injection wells and a preparation method thereof The anti-scaling agent is prepared from starting materials comprising: 10 to 12 parts of non-ionic surfactant(s), 18 to 20 parts of hexasodium triethylenetetramine-N,N,N,N,N,N-hexaacetate, 5 to 8 parts of anionic surfactant(s), 6 to 8 parts of an organic phosphonic acid-carboxylic acid scale inhibitor, 2 to 5 parts of a dispersant, 15 to 18 parts of a diluent, 8 to 10 parts of an organic amine salt, and 30 to 36 parts of water. The pressure-reducing and injection-enhancing agent according to the present disclosure is characterized by having multiple functions in one agent. When used in an amount being 0.5% of the water injected to a water injection well, it shows excellent anti-swelling property, shrinking property, anti-corrosive property, and calcium sulfate and barium (strontium) sulfate scale resistance.

The present disclosure provides a pressure-reducing and injection-enhancing anti-scaling agent for low-permeability water-injection wells and a preparation method thereof The anti-scaling agent is prepared from starting materials comprising: 10 to 12 parts of non-ionic surfactant(s), 18 to 20 parts of hexasodium triethylenetetramine-N,N,N,N,N,N-hexaacetate, 5 to 8 parts of anionic surfactant(s), 6 to 8 parts of an organic phosphonic acid-carboxylic acid scale inhibitor, 2 to 5 parts of a dispersant, 15 to 18 parts of a diluent, 8 to 10 parts of an organic amine salt, and 30 to 36 parts of water. The pressure-reducing and injection-enhancing agent according to the present disclosure is characterized by having multiple functions in one agent. When used in an amount being 0.5% of the water injected to a water injection well, it shows excellent anti-swelling property, shrinking property, anti-corrosive property, and calcium sulfate and barium (strontium) sulfate scale resistance.

Disclosed are compositions and methods for inactivating one or more enzymes in a biological sample.

The present invention relates to a process for preparing a porous metal-organic framework by reacting at least one metal compound in which the metal is Be, Mg, Ca, Sr, Ba, Al, Ga or In with at least one at least bidentate organic compound and also the use of such porous metal-organic frameworks.